Clostridium difficile Toxins: Mediators of Inflammation

被引:132
|
作者
Shen, Aimee [1 ]
机构
[1] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05401 USA
关键词
Glucosylating toxin; Binary toxin; Clostridium difficile infection; Hypervirulence; BINARY TOXIN; GLUCOSYLATING TOXINS; RHO-GTPASES; SEVERE DISEASE; INFECTION; STRAINS; BINDING; TCDB; ACTIVATION; APOPTOSIS;
D O I
10.1159/000332946
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clostridium difficile is a significant problem in hospital settings as the most common cause of nosocomial diarrhea worldwide. C. difficile infections (CDIs) are characterized by an acute intestinal inflammatory response with neutrophil infiltration. These symptoms are primarily caused by the glucosylating toxins, TcdA and TcdB. In the past decade, the frequency and severity of CDIs have increased markedly due to the emergence of so-called hypervirulent strains that overproduce cytotoxic glucosylating toxins relative to historical strains. In addition, these strains produce a third toxin, binary toxin or C. difficile transferase (CDT), that may contribute to hypervirulence. Both the glucosylating toxins and CDT covalently modify target cell proteins to cause disassembly of the actin cytoskeleton and induce severe inflammation. This review summarizes our current knowledge of the mechanisms by which glucosylating toxins and CDT disrupt target cell function, alter host physiology and stimulate immune responses. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:149 / 158
页数:10
相关论文
共 50 条
  • [31] Toward a structural understanding of Clostridium difficile toxins A and B
    Pruitt, Rory N.
    Lacy, D. Borden
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2012, 2
  • [32] TcdB or not TcdB: a tale of two Clostridium difficile toxins
    Carter, Glen P.
    Awad, Milena M.
    Kelly, Michelle L.
    Rood, Julian I.
    Lyras, Dena
    FUTURE MICROBIOLOGY, 2011, 6 (02) : 121 - 123
  • [33] Revised nomenclature of Clostridium difficile toxins and associated genes
    Rupnik, M
    Dupuy, B
    Fairweather, NF
    Gerding, DN
    Johnson, S
    Just, I
    Lyerly, DM
    Popoff, MR
    Rood, JI
    Sonenshein, AL
    Thelestam, M
    Wren, BW
    Wilkins, TD
    von Eichel-Streiber, C
    JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 54 (02) : 113 - 117
  • [34] TOXINS TCD A AND B OF CLOSTRIDIUM DIFFICILE FOR HORSE IMMUNIZATION
    Artiuslun, Sergey
    JOURNAL OF EQUINE VETERINARY SCIENCE, 2010, 30 (10) : 536 - 536
  • [35] Immunological Stability of Clostridium difficile Toxins in Clinical Specimens
    Schora, Donna M.
    Peterson, Lance R.
    Usacheva, Elena A.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2018, 39 (04): : 434 - 438
  • [36] The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins
    Chen, Shuyi
    Sun, Chunli
    Wang, Haiying
    Wang, Jufang
    TOXINS, 2015, 7 (12): : 5254 - 5267
  • [37] ACTIVATION OF HUMAN MONOCYTES BY CLOSTRIDIUM-DIFFICILE TOXINS
    LINEVSKY, JK
    KEATES, S
    SIEGENBERG, D
    POTHOULAKIS, C
    LAMONT, JT
    KELLY, CP
    GASTROENTEROLOGY, 1993, 104 (04) : A732 - A732
  • [38] Receptors and Binding Structures for Clostridium difficile Toxins A and B
    Gerhard, Ralf
    UPTAKE AND TRAFFICKING OF PROTEIN TOXINS, 2017, 406 : 79 - 96
  • [39] Pathogenic effects of glucosyltransferase from Clostridium difficile toxins
    Zhang, Yongrong
    Feng, Hanping
    PATHOGENS AND DISEASE, 2016, 74 (04): : ftw024
  • [40] Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
    Lowy, Israel
    Molrine, Deborah C.
    Leav, Brett A.
    Blair, Barbra M.
    Baxter, Roger
    Gerding, Dale N.
    Nichol, Geoffrey
    Thomas, William D., Jr.
    Leney, Mark
    Sloan, Susan
    Hay, Catherine A.
    Ambrosino, Donna M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (03): : 197 - 205